These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9668261)

  • 1. Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region.
    Hjelmström P; Peacock CS; Giscombe R; Pirskanen R; Lefvert AK; Blackwell JM; Sanjeevi CB
    Ann N Y Acad Sci; 1998 May; 841():368-70. PubMed ID: 9668261
    [No Abstract]   [Full Text] [Related]  

  • 2. TAP polymorphisms in Swedish myasthenia gravis patients.
    Hjelmström P; Giscombe R; Lefvert AK; Pirskanen R; Kockum I; Landin-Olsson M; Sanjeevi CB
    Tissue Antigens; 1997 Feb; 49(2):176-9. PubMed ID: 9062975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis.
    Huang DR; Pirskanen R; Matell G; Lefvert AK
    J Neuroimmunol; 1999 Feb; 94(1-2):165-71. PubMed ID: 10376950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour necrosis factor beta gene polymorphisms in myasthenia gravis.
    Zelano G; Lino MM; Evoli A; Settesoldi D; Batocchi AP; Torrente I; Tonali PA
    Eur J Immunogenet; 1998 Dec; 25(6):403-8. PubMed ID: 9949945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in tumor necrosis factor genes associated with myasthenia gravis.
    Hjelmström P; Peacock CS; Giscombe R; Pirskanen R; Lefvert AK; Blackwell JM; Sanjeevi CB
    J Neuroimmunol; 1998 Aug; 88(1-2):137-43. PubMed ID: 9688335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis.
    Carlsson B; Wallin J; Pirskanen R; Matell G; Smith CI
    Immunogenetics; 1990; 31(5-6):285-90. PubMed ID: 1973409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1 and TAP2.
    Ivansson EL; Magnusson JJ; Magnusson PK; Erlich HA; Gyllensten UB
    Genes Immun; 2008 Oct; 9(7):613-23. PubMed ID: 18650831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis.
    Hjelmström P; Giscombe R; Lefvert AK; Pirskanen R; Kockum I; Landin-Olsson M; Sanjeevi CB
    J Neuroimmunol; 1996 Apr; 65(2):125-31. PubMed ID: 8964894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DQ restriction fragment length polymorphisms in myasthenia gravis.
    Bell JI; Steinman L; Toyka K; McDevitt HO
    Ann N Y Acad Sci; 1987; 505():382-7. PubMed ID: 2891337
    [No Abstract]   [Full Text] [Related]  

  • 10. Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies.
    Giraud M; Beaurain G; Yamamoto AM; Eymard B; Tranchant C; Gajdos P; Garchon HJ
    Neurology; 2001 Nov; 57(9):1555-60. PubMed ID: 11706089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the AChRalpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients.
    Djabiri F; Caillat-Zucman S; Gajdos P; Jaïs JP; Gomez L; Khalil I; Charron D; Bach JF; Garchon HJ
    J Autoimmun; 1997 Aug; 10(4):407-13. PubMed ID: 9237805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated characterization of ancestral haplotypes using the Fourth Asia-Oceania Histocompatibility Workshop panel.
    Degli-Esposti MA; Leelayuwat C; Daly LN; Carcassi C; Contu L; Versluis LF; Tilanus MG; Dawkins RL
    Hum Immunol; 1995 Sep; 44(1):12-8. PubMed ID: 8522450
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of
    Yang HW; Wang YX; Bao J; Wang SH; Lei P; Sun ZL
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28119492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes.
    Degli-Esposti MA; Andreas A; Christiansen FT; Schalke B; Albert E; Dawkins RL
    Immunogenetics; 1992; 35(6):355-64. PubMed ID: 1349584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of thymic pathology with HLA in myasthenia gravis.
    Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
    Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association of the HLA-DQ alleles with myasthenia gravis in Cuban patients.
    Sylvia T; Samuel M; Luis G; Zuzet M
    Hum Immunol; 2013 Aug; 74(8):983-5. PubMed ID: 23628390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA and Singaporean Chinese myasthenia gravis.
    Chan SH; Tan CB; Lin YN; Wee GB; Degli-Esposti MA; Dawkins RL
    Int Arch Allergy Immunol; 1993; 101(2):119-25. PubMed ID: 8508049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HLA-DQ molecules associated with myasthenia gravis in Chinese patients].
    Li X; Zhang KX; Fan YX; Chen XZ; Zuo J; Pan XH; Zhu DL; Geng ZC
    Yi Chuan Xue Bao; 1999; 26(4):295-300. PubMed ID: 10593018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-encoded DQ alpha beta heterodimers confer susceptibility to myasthenia gravis disease.
    Khalil I; Berrih-Aknin S; Lepage V; Loste MN; Gajdos P; Hors J; Charron D; Degos L
    C R Acad Sci III; 1993 Jul; 316(7):652-60. PubMed ID: 8019886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci.
    Giraud M; Beaurain G; Eymard B; Tranchant C; Gajdos P; Garchon HJ
    Genes Immun; 2004 Aug; 5(5):398-404. PubMed ID: 15201863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.